Novartis Ag (NVS) Return on Sales (2009 - 2025)

Novartis Ag (NVS) has 15 years of Return on Sales data on file, last reported at 0.0% in Q2 2025.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Sales grew to 0.0% in Q2 2025 per NVS's latest filing, from 0.0% in the prior quarter.
• The five-year high for Return on Sales was 1323.01% in Q1 2022, with the low at 0.0% in Q4 2023.
• Average Return on Sales over 5 years is 94.51%, with a median of 0.0% recorded in 2024.
• Year-over-year, Return on Sales jumped 132296 bps in 2022 and plunged 132301 bps in 2023.
• Novartis Ag's Return on Sales stood at 0.0% in 2021, then surged by 128 bps to 0.01% in 2022, then sank by 100 bps to 0.0% in 2023, then surged by 2000000000 bps to 0.0% in 2024, then advanced by 17 bps to 0.0% in 2025.
• Business Quant data shows NVS's Return on Sales at 0.0% in Q2 2025, 0.0% in Q4 2024, and 0.0% in Q2 2024.